S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas W. Flaig, M.D.
University of Colorado, Denver
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
566 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- University of Arizona Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Yuma Cancer Center
Yuma, Arizona, United States
- Fowler Family Center for Cancer Care
Jonesboro, Arkansas, United States
- Ais Cancer Center at San Joaquin Community Hospital
Bakersfield, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Usc Norris Oncology/hematology-Newport Beach
Newport Beach, California, United States
- Stanford Cancer Institute
Palo Alto, California, United States
- Pcr Oncology
Pismo Beach, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Stanford Cancer Center South Bay
San Jose, California, United States
- City of Hope South Pasadena
South Pasadena, California, United States
- Gene Upshaw Memorial Tahoe Forest Cancer Center
Truckee, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Memorial Hospital Central
Colorado Springs, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Colorado Cancer Research Program Ncorp
Denver, Colorado, United States
- Denver Health Medical Center
Denver, Colorado, United States
- National Jewish Health-Main Campus
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Aug 2014
- Primary completion
- 29 Feb 2020
- Completion
- 1 Dec 2022
- Last update posted
- 19 Sept 2024
- Registered enrollment
- 237
- Registry id
- NCT02177695
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.